Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CDK Global $755 million notes offering
We advised CDK Global on the transaction
Gracell Biotechnologies PIPE of ordinary shares and warrants
The company’s ADSs are listed on Nasdaq
Avon $194 million tender offer
We advised Avon on its tender offer for outstanding 6.95% notes due 2043
Regency Centers $500 million at-the-market offering
The shares are listed on Nasdaq
Banco Santander $3.5 billion notes offering
We advised Banco Santander on its offering of fixed-rate notes
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
MicroStrategy $750 million at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Hayward Holdings $317 million secondary offering
The stock is listed on the New York Stock Exchange
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
British American Tobacco $5 billion notes offering and cash tender offer
The offering is composed of five tranches of notes